Correlation Between Seres Therapeutics and Entera Bio

Can any of the company-specific risk be diversified away by investing in both Seres Therapeutics and Entera Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Seres Therapeutics and Entera Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Seres Therapeutics and Entera Bio, you can compare the effects of market volatilities on Seres Therapeutics and Entera Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Seres Therapeutics with a short position of Entera Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Seres Therapeutics and Entera Bio.

Diversification Opportunities for Seres Therapeutics and Entera Bio

0.52

Correlation Coefficient

Seres Therapeutics  Entera Bio

Very weak diversification

The 3 months correlation between Seres and Entera is 0.52. Overlapping area represents the amount of risk that can be diversified away by holding Seres Therapeutics and Entera Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Entera Bio and Seres Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Seres Therapeutics are associated (or correlated) with Entera Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Entera Bio has no effect on the direction of Seres Therapeutics i.e., Seres Therapeutics and Entera Bio go up and down completely randomly.

Pair Corralation between Seres Therapeutics and Entera Bio

Given the investment horizon of 90 days Seres Therapeutics is expected to generate 1.06 times more return on investment than Entera Bio. However, Seres Therapeutics is 1.06 times more volatile than Entera Bio. It trades about 0.0 of its potential returns per unit of risk. Entera Bio is currently generating about -0.04 per unit of risk. If you would invest  83.00  in Seres Therapeutics on December 28, 2024 and sell it today you would lose (7.00) from holding Seres Therapeutics or give up 8.43% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Seres Therapeutics  vs.  Entera Bio

Seres Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Seres Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Seres Therapeutics is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.

Entera Bio

Risk-Adjusted Performance

Very Weak

Over the last 90 days Entera Bio has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Pair Trading with Seres Therapeutics and Entera Bio

The main advantage of trading using opposite Seres Therapeutics and Entera Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Seres Therapeutics position performs unexpectedly, Entera Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Entera Bio will offset losses from the drop in Entera Bio's long position.

The idea behind Seres Therapeutics and Entera Bio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.